Roche Joins Massachusetts Program to Support Early Stage LS Companies | GenomeWeb

NEW YORK (GenomeWeb) – The Massachusetts Life Sciences Center today said that Roche has joined the Center's Corporate Consortium Partners to support early stage life science firms in the state.

As a member, Roche will provide funding to support MLSC's investments in such businesses, and in return, Roche will have access to new technologies that may potentially lead to new healthcare solutions, MLSC said. According to an MLSC spokesperson, Roche will provide $250,000 to the consortium partner program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.